Main sponsors

Seit seiner Gründung im Jahr 2010 hat sich die Moderna Inc. mit Hauptsitz in Cambridge, Mass. (USA), von einem forschungsorientierten Unternehmen, das auf dem Gebiet der Messenger-RNA (mRNA) tätig ist, zu einem mRNA-Pionier und weltweit bekannten Biotechnologieunternehmen entwickelt. Das klinische Portfolio im Bereich der mRNA-Imfstoffe und -Therapeutika erstreckt sich über sechs verschiedene Forschungsgebiete. Zudem verfügt das Unternehmen über Patente in Bereichen wie der Formulierung von mRNA und Lipid-Nano-Partikeln (LNPs). Eigens entwickelte Produktionsanlagen ermöglichen eine flexible und schnelle Produktion von Impfstoffen und Therapeutika.  

Moderna arbeitet weltweit mit einer Vielzahl an Partnern zusammen, um neben bahnbrechender Wissenschaft auch eine schnelle Skalierung der Produktion zu ermöglichen. Das Know-how von Moderna und der unermüdliche Einsatz aller Mitarbeitenden haben zur Zulassung einer der ersten wirksamen mRNA-Impfstoffe zur COVID-19-Pandemiebekämpfung geführt.  

Die mRNA-Plattform von Moderna basiert auf kontinuierlichen Fortschritten in der Grundlagen- und angewandten mRNA-Forschung, den Applikationsformen sowie der Herstellung. Sie ermöglicht die Entwicklung von Therapeutika und Impfstoffen für Infektionskrankheiten, in der Immunonkologie, gegen seltene Krankheiten, Herz-Kreislauf-Erkrankungen und Autoimmunerkrankungen.  

2022 wurde Moderna von Science zum achten Mal in Folge als einer der besten Arbeitgeber in der globalen biopharmazeutischen Industrie ausgezeichnet. Um mehr zu erfahren, besuchen Sie www.modernatx.com. Seit Oktober 2021 ist das US-amerikanische Unternehmen als Moderna Germany GmbH mit einer Niederlassung in München, Deutschland, vertreten. Um mehr zu erfahren, besuchen Sie https://www.modernatx.com/de-DE.

At the heart of QIAGEN’s business is a vision for making improvements in life possible. We deliver on this promise by providing differentiating Sample to Insight solutions that help our customers to unlock valuaschble molecular insights encoded in the building blocks of life.

Some of the great challenges facing the world – issues of life and death, health and disease, continuity and change – find their causes in the near-infinite diversity of genomic molecules that serve as the building blocks of all life. Scientists, doctors, lab directors and other professionals committed to answering life’s questions look to QIAGEN for solutions in molecular testing.

QIAGEN is known to more than 500,000 customers around the world for our innovation, engagement, integrity, quality and passion. This identity creates relationships for our global team across the continuum from research in the life sciences, to molecular diagnostics and public safety applications in everyday use.

Our mission is to deliver Sample to Insight solutions enabling QIAGEN customers to unlock valuable molecular insights faster, better and more efficiently – from the raw biological sample to the final interpreted result. 

QIAGEN is committed to making improvements in life possible.

qiagen.com

ELITechGroup Molecular Diagnostics serves the needs of clinical laboratories, offering an extensive portfolio of molecular diagnostics products including the fully automated sample-to-result systems ELITe® InGenius and ELITe® BeGenius.
 The company has developed a broad menu of solutions including more than 45 CE-IVD assays, instruments and software, guaranteeing superior workflows design and enhanced performances. All our solutions are already on track to be IVDR compliant within the targets of the new directive.

elitechgroup.com

GeneTex is a multinational antibody manufacturer with 25 years of experience producing immunological reagents for biomedical research. The company maintains a broad range of primary antibodies in polyclonal and hybridoma-based monoclonal formats, but now prioritizes its robust recombinant monoclonal antibody production platform. A core focus area of GeneTex’s catalog is molecular virology, and the company has established an extensive portfolio of highly validated and cited reagents against flavivirus pathogens, SARS-CoV-2, influenza viruses, Ebola virus, hepatitis viruses, HIV, enteroviruses, and human papillomavirus. New products against emerging infectious diseases, RSV, VEEV, Chikungunya virus, and porcine viruses are being continuously developed by GeneTex.

genetex.com

Unsere 17.500 Mitarbeitenden in Deutschland arbeiten Tag um Tag mit viel Leidenschaft daran, die Gesundheit von Menschen zu verbessern. Wir erforschen, entwickeln, produzieren und vertreiben Medikamente, diagnostische Lösungen & digitale Technologien an den Standorten Mannheim, Penzberg, Grenzach-Wyhlen und Ludwigsburg – für eine bessere Gesundheitsversorgung. So tragen wir zum medizinischen Fortschritt bei und ermöglichen Patient:innen ein besseres Leben. Wir stellen den Menschen in den Mittelpunkt. Die Philanthropie hat bei Roche seit mehr als einem Jahrhundert Tradition.

Seegene Germany GmbH was founded in 2017 in Düsseldorf as a subsidiary of Seegene Inc., with its headquarters in Seoul, South Korea. The company is the global leader in multiplex real-time PCR diagnostics. With more than 50 employees, Seegene Germany GmbH develops and distributes innovative in-vitro diagnostics based on Seegene's own patented multiplex technologies. In addition to real-time PCR, Seegene uses its own detailed molecular biological solutions (DPOTM, TOCETM, MuDTTM), which enable a unique degree of multiplexing and thus allow the direct detection of a wide range of infectious pathogens. Our Assay portfolio offers over 180 pathogens. More information: www.seegene.de.

altona Diagnostics is a medical diagnostic company that develops and manufactures in vitro diagnostic tests for the PCR based detection of pathogens such as viruses, bacteria or parasites. Headquartered in Hamburg-Altona, Germany, altona Diagnostics is privately owned and employs more than 350 people worldwide.

altona-diagnostics.com

Genetic Signatures improves patient care with innovative multiplex PCR solutions, underpinned by patented 3baseTM technology. Automated diagnostic workflows enable laboratories to employ syndromic testing to accurately screen for a wide range of infectious diseases in a single test. Results are delivered within hours, compared to days for traditional methods, supporting appropriate infection control and patient management.

geneticsignatures.com

Particle Metrix has made a name as innovative manufacturer of nanoparticle tracking analyzers. We specialized in the characterization of extracellular vesicles, exosomes, liposomes and viruses, using both scatter and fluorescence-based methods. The focus is on determining the size and concentration as well as measuring zeta potential of particles in the nanometer scale.

particle-metrix.com

Working in the fields of clinical diagnostics, food and feed analysis and nutrition care, R-Biopharm employs its innovative and reliable products to develop pioneering solutions for successful worldwide distribution. In the clinical field, R-Biopharm offers IVD test systems for the identification of antigens and antibodies of infectious diseases, as well as test systems for allergy diagnostics, gastroenterology, molecular diagnostics and TDM using methods like ELISAs, Rapid Tests, Blots and PCR.

r-biopharm.com

Spindiag's goal is to provide rapid test results easily: The Rhonda PCR platform enables reliable infection control at the point of care in well under one hour. 
The product portfolio currently includes the following PCR tests:

• SARS-CoV-2
• Respi: SARS-CoV-2 (DT), Influenza A/B, RSV
• MRSA

Discover Rhonda:

www.spindiag.de

Takara Bio Europe is a subsidiary of Takara Bio Inc., who offers a wide range of life science solutions under the Takara™, Clontech®, and Cellartis® brands. Key products include synthesis kits for a variety of applications, including NGS, high-performance qPCR and PCR, stem cells solutions, cloning system, gene editing tools.

takarabio.com